News

How do you care for atopic eczema? EFA at the EADV Virtual Congress

26 November 2020
Allergy, Other Diseases
- Patient Evidence, - Healthcare, - Quality of Life
Representing European atopic eczema patients, EFA took part in the annual  Congress of the European Academy of Dermatology and Venerology (EADV) that...

Europe’s Zero Pollution Action Plan: the chance for an air quality framework for better health

12 November 2020
Asthma , COPD
- Air Quality
Clean air is central to human health and essential to the wellbeing and quality of life for people with allergies and airways diseases. In 2021, the European...

The EU’s Renovation Wave champions green homes to reduce pollution but lacks health as a priority

28 October 2020
Asthma , COPD, Allergy
PREVENT, - Air Quality
This month the European Commission published its Renovation Wave Strategy. This strategy outlines detailed plans to increase the energy efficiency of building...

Highlights from the Annual Stakeholder meeting of the EU Human Biomonitoring project – HBM4EU

15 October 2020
Asthma , COPD, Allergy
INFORM, - Research Projects, PREVENT, - Chemicals
EFA participated and gave a short presentation to the Annual Stakeholder Forum of the EU Human Biomonitoring project on 30 September. The project, called...

European Parliament pushes for a 60% emissions reduction target in the new Climate Law

15 October 2020
Asthma , COPD, Allergy
PREVENT, - Air Quality
At the start of October, the European Parliament voted to adopt an EU Climate Law with increased ambitions. The biggest news was MEPs calling for a 60%...

EFA participates in the 43rd Session of the Codex Alimentarius Commission

07 October 2020
Food Allergy
- Food Safety
The 43rd annual session of the Codex Alimentarius Commission (CAC) was held from 24-26th September, and 12th and 19th October. It will also take place...

EFA allergy and respiratory patients conference

23 September 2020
Asthma , COPD
INFORM, - Patient Evidence, - Expert Patient Network
Digitalisation brings an enormous potential to improve health and care and the lives of patients. With new and emerging technologies, healthcare systems...

EFA response to the new EU Pharmaceutical Strategy: towards safe and more accessible medicines

23 September 2020
CARE, - Healthcare, - Medicines
Launched in the midst of the COVID-19 crisis, the EU Pharmaceutical Strategy draft is an initiative that, along with the Beating Cancer Plan, tops the...

AEPNAA releases guide on food allergies for educational centres in Spain

23 September 2020
Spain
Allergy, Food Allergy
- Food Safety
EFA Member the Spanish Association of People with Food and Latex Allergy (AEPNAA) have created a guide for educational centres in Spain to understand food...

New Danish study on peanut allergies

23 September 2020
Denmark
Food Allergy
EFA Member Asthma-Allergy Denmark has contributed to a study which reveals how peanut allergy affects the psyche. The study explored how limitations in...

Longfonds supports study of COVID-19 effect on lung tissue

23 September 2020
Netherlands
Other Diseases
- Research Projects
Longfonds have supported a study by LUMC where scientists are investigating how lung tissue reacts to the coronavirus. This research uses a so-called Long...

Smoking ban extended to e-cigarettes in the Netherlands

23 September 2020
Netherlands
Asthma , COPD, Other Diseases
- Tobacco & Smoking
Vaping and vaporising is no longer allowed in public from 1 July in the Netherlands, as part of an extension of the smoking ban to include e-cigarettes. This...

We joined World Patient Safety Day on September 17th!

23 September 2020
CARE
17th September is celebrated around the world as World Patient Safety Day. Organised by the World Health Organisation, the day is used to advocate for...

EFA Patients highlights from 2020 online ERS Congress

23 September 2020
Asthma , COPD
CARE, - Healthcare
Although this year it was particularly difficult to choose among the variety and intense 4 full days programme at the 2020 European Respiratory Society...

EFA Food DETECTives Project

23 September 2020
Allergy, Food Allergy
- Research Projects, - Food Safety
In Europe, 17 million people live with food allergies, and the safest option available today remains avoiding the food they are allergic to. Yet this requires...

First CURE project findings published!

23 September 2020
Asthma
- Research Projects
The CURE project is now in its third year of research, entering a period of evidence production. On August 4th, the first publication steaming from the...

ImmUniverse: Improving diagnostic and therapeutic options for atopic eczema patients

23 September 2020
Other Diseases
- Research Projects
Through ImmUniverse, EFA is involved in research aiming at improving diagnostic and therapeutic options for patients living with immune-mediated inflammatory...

3TR: young and senior asthma and COPD patients involved in biomarker research

23 September 2020
Asthma , COPD
- Patient Evidence, - Research Projects
3TR is a high-end research project that aims at improving treatment available for asthma and COPD. Funded by the Innovative Medicine Initiative (IMI),...

EFA response to the review of the EU Regulation on Fluorinated Greenhouse Gases

23 September 2020
Asthma , COPD
INFORM, - Medicines
In September EFA participated in the Inception Impact Assessment consultation launched by the European Commission Directorate General for Climate Action...

The psychological burden of atopic eczema will be discussed at the EADV Congress

23 September 2020
Asthma , COPD, Allergy, Food Allergy
CARE, - Healthcare, - Digital Health
The 2020 EADV Congress will take place from the 29-31 of October, as a global virtual event. Do not miss EFA’s session on the socio-psychological burden...

Dear Visitor,

for regularly updated information on Covid-19 for allergy and respiratory patients, please consult our Covid-19 resource and information hub.
Stay safe!
The EFA Team